This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Targeting Pim kinases in hematological cancers: molecular and clinical review
Molecular Cancer Open Access 25 January 2023
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jaffe ES, Harris NL, Stein H, Vardiman JW . World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.
van Besien K, Kelta M, Bahaguna P . Primary mediastinal B-cell lymphoma: a review of pathology and management. J Clin Oncol 2001; 19: 1855–1864.
Pasqualucci L, Neumeister P, Goossens T, Nanjangud G, Chaganti RS, Kuppers R et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature 2001; 412: 341–346.
Bodor C, Bognar A, Reiniger L, Szepesi A, Toth E, Kopper L et al. Aberrant somatic hypermutation and expression of activation-induced cytidine deaminase mRNA in mediastinal large B-cell lymphoma. Br J Haematol 2005; 129: 373–376.
Malpeli G, Barbi S, Moore PS, Scardoni M, Chilosi M, Scarpa A et al. Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene targets motifs different from those in diffuse large B-cell and follicular lymphomas. Haematologica 2004; 89: 1091–1099.
Pasqualucci L, Migliazza A, Basso K, Houldsworth J, Chaganti RS, Dalla-Favera R . Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 2003; 101: 2914–2923.
Cesarman E, Dalla-Favera R, Bentley D, Groudine M . Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science 1987; 238: 1272–1275.
Gu W, Bhatia K, Magrath IT, Dang CV, Dalla-Favera R . Binding and suppression of the Myc transcriptional activation domain by p107. Science 1994; 264: 251–254.
Acknowledgements
This study has been supported by Ricerca Sanitaria Finalizzata and Ricerca Scientifica Applicata, Regione Piemonte, Torino, Italy; PRIN 2005 – MIUR, Rome, Italy; Istituto Superiore di Sanità, Programma Nazionale di Ricerca sull'AIDS – Progetto Patologia, Clinica e Terapia dell'AIDS, Rome, Italy; AIRC, Milan, Italy; and Novara-AIL Onlus, Novara, Italy. EB has been supported by Fondazione ‘Piera Pietro Giovanni Ferrero’, Alba, Italy. LP is a special fellow of the Leukemia & Lymhpoma Society.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rossi, D., Cerri, M., Capello, D. et al. Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. Leukemia 19, 2363–2366 (2005). https://doi.org/10.1038/sj.leu.2403982
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403982
This article is cited by
-
Targeting Pim kinases in hematological cancers: molecular and clinical review
Molecular Cancer (2023)
-
Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma
Modern Pathology (2019)
-
Primary Cutaneous Marginal Zone B-Cell Lymphomas Are Targeted by Aberrant Somatic Hypermutation
Journal of Investigative Dermatology (2009)